XML 16 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Nature of the Business - Additional Information (Detail) (USD $)
In Millions, unless otherwise specified
6 Months Ended
Jun. 30, 2014
Candidate
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Number of novel therapeutic oncology candidates 6
Unrestricted cash and cash equivalents and available-for-sale securities $ 92.7
Agreement termination scheduled date Dec. 17, 2014